I earned my PhD in Kinesiology & Health Science at York University working under the supervision of Dr. Olivier Birot. My doctoral research investigated skeletal muscle microvascular adaptability in health and disease, with a special interest on molecular factors regulating capillary growth and/or regression in response to both physiological (exercise) and pathological (diabetes) stimuli. My current post-doctoral research aims to improve our understanding of the biology of somatostatin receptor type 2 (SSTR2) antagonism to prevent hypoglycemia using animal models of type 1 diabetes, ultimately setting the stage for phase 1 and 2 clinical studies in humans. In my free time, I enjoy playing and watching basketball, going to the gym, playing guitar, and travelling.
I completed my MSc in Kinesiology & Health Science at York University under the supervision of Dr. Anthony Scimè. Currently, I am investigating the effects of sodium glucose co-transporter-2 (SGLT-2) inhibitors and somatostatin receptor type 2 (SSTR2) antagonists on glucose counterregulation in type 1 diabetes for improving hypoglycemia prevention. Outside of the lab, I enjoy travelling, cooking, reading, and trying new foods.
MSc Year 1
I received a BSc in Biology from the University of Guelph and a BA in Kinesiology & Health Science from York University. Joining the Riddell Lab as an undergraduate student, I collaborated with a biotechnology company to develop a protocol for the extraction and quantification of pancreatic hormones. I continued in the lab as a research assistant and now graduate student, investigating somatostatin as a hormonal mediator of counterregulatory dysfunction in type 2 diabetes. To help alleviate the disease burden, I am evaluating the therapeutic potential of somatostatin receptor type-2 antagonists (SSTR2a) for the prevention of hypoglycemia in diabetic individuals. In my free time, I enjoy playing ultimate frisbee and watching Jeopardy.